Omnicell (OMCL) Tops Q3 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Omnicell (OMCL) PT Raised to $155 at Cantor Fitzgerald
November 2, 2021 11:38 AM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Omnicell (NASDAQ: OMCL) to $155.00 (from $135.00) while maintaining a Neutral rating.
The analyst commented, "We reiterate our Neutral rating on OMCL shares but increase our 12-month, DCF-based price target to $155 (compared to $135 previously). This morning, November 2, the company reported 3Q21 results that were ahead of our estimates and FactSet consensus. Revenue was $296 million compared to our estimate of $284 million. Revenue... More
Omnicell's (OMCL) Central Pharmacy Dispensing Service Selected by Tucson VA Medical Center
November 2, 2021 7:36 AM EDTOmnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Tucson VA Medical Center has chosen the Companys... More
